XML 35 R24.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Product Information [Line Items]          
Cash FDIC insurance $ 250,000   $ 250,000    
Cash SIPC insurance 500,000   500,000    
Patent and licensing costs 108,193 $ 143,444 228,352 $ 276,912  
Unrecognized tax benefits $ 0   $ 0   $ 0
Deferred setup and organization costs, amortization period     12 months    
Cost of Sales [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member]          
Product Information [Line Items]          
Concentration of risk, percentage     10.00% 10.00%  
General and Administrative Expense [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member]          
Product Information [Line Items]          
Concentration of risk, percentage 7.50% 56.30% 8.40% 50.70%  
Research and Development Expense [Member] | Revenue Benchmark [Member] | One Vendors and Consultants [Member]          
Product Information [Line Items]          
Concentration of risk, percentage 26.30% 36.80% 43.80% 28.30%  
Research and Development Expense [Member] | Revenue Benchmark [Member] | Two Vendors and Consultants [Member]          
Product Information [Line Items]          
Concentration of risk, percentage 26.00% 25.60% 19.70% 20.40%  
Research and Development Expense [Member] | Revenue Benchmark [Member] | Three Vendors and Consultants [Member]          
Product Information [Line Items]          
Concentration of risk, percentage 11.40% 10.50%   15.10%  
Research and Development Expense [Member] | Revenue Benchmark [Member] | Four Vendors And Consultants [Member]          
Product Information [Line Items]          
Concentration of risk, percentage       11.90%